Upgrade to SI Premium - Free Trial

Cytodyn Inc. (CYDY)

0.21 +0.01 (5.00%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (7/29/26)

Latest Headlines

Natera partners with CytoDyn for colorectal cancer drug development June 4, 2026 8:01 AM - StreetInsider Natera and CytoDyn Announce Strategic Collaboration to Advance ctDNA-Guided Development and Molecular Response Analysis in Metastatic Colorectal Cancer June 4, 2026 8:00 AM - BizWire Form EFFECT CytoDyn Inc. May 21, 2026 6:04 AM - SEC Filing Form 424B3 CytoDyn Inc. May 20, 2026 5:09 PM - SEC Filing CytoDyn to Present at the LD Micro Invitational XVI May 15, 2026 8:30 AM - Globe NewsWire CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities May 11, 2026 8:30 AM - Globe NewsWire Form D CytoDyn Inc. May 11, 2026 6:02 AM - SEC Filing Form 8-K CytoDyn Inc. For: Apr 30 April 30, 2026 4:35 PM - SEC Filing CytoDyn Announces First Patient Dosed in Expanded Access Program for Leronlimab in Triple-Negative Breast Cancer April 27, 2026 8:30 AM - Globe NewsWire CytoDyn to Host Investor Webcast April 23, 2026 8:31 AM - Globe NewsWire Full Article List